Aet Biotechnologie Technographics
Aet Biotechnologie Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Aet Biotechnologie and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 16 Aet Biotechnologie employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Aet Biotechnologie has purchased the following applications: Microsoft 365 for Collaboration in 2021, DocuSign eSignature for Digital Signing in 2021, Google Tag Manager for Tag Management in 2020 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Aet Biotechnologie is running and its propensity to invest more and deepen its relationship with Microsoft , Docusign , Google or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Aet Biotechnologie revenues, which have grown to $1.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Aet Biotechnologie intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Aet Biotechnologie Tech Stack and Enterprise Applications
Aet Biotechnologie Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2021 | 2021 |
In 2021 Aet Biotechnologie implemented Microsoft 365 to support Collaboration across its life sciences operations. The deployment is visible on the company website, indicating Microsoft 365 is used on their website. The initiative targets core productivity, team communication and document sharing for a 16 person organization.
Microsoft 365 is positioned as the primary Collaboration platform and is expected to provide Exchange Online, Microsoft Teams, SharePoint and OneDrive capabilities for email, meetings, document collaboration and file storage. Administrative control is concentrated at the tenant level with user account provisioning and role based access controls to manage permissions across corporate functions. Aet Biotechnologie Microsoft 365 Collaboration supports internal communication, knowledge work and administrative business functions through centralized administration, shared document libraries and real time collaboration workflows.
|
Aet Biotechnologie Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Docusign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021, Aet Biotechnologie deployed DocuSign eSignature as a Digital Signing solution to enable digital signature capture directly on its public website for customer and partner agreements. The deployment centers on embedded signing workflows and web-based envelope initiation, providing a hosted signing ceremony, recipient routing, and an auditable transaction history tied to documents surfaced through site interactions. Aet Biotechnologie DocuSign eSignature Digital Signing supports the companys external contract execution and consent capture use cases for a small life sciences firm.
The implementation leverages core DocuSign eSignature capabilities consistent with Digital Signing category functionality, including envelope creation, recipient authentication steps, signing ceremony orchestration, and audit trail preservation for compliance purposes. Operational coverage is focused on website-driven document workflows that touch commercial and regulatory documentation, with governance oriented around documented signing processes and retention of transaction records. The architecture is web-embedded, minimizing on-premise footprint and aligning signature capture directly with customer-facing document flows on the aet.eu site.
|
Aet Biotechnologie CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Legacy | Google Tag Manager | Tag Management | CRM | n/a | 2020 | 2020 |
In 2020, Aet Biotechnologie implemented Google Tag Manager on its corporate website. Google Tag Manager serves as the Tag Management layer to centralize client side tag orchestration, container management, and analytics instrumentation for the site.
Deployment used a single web container embedded across the site, leveraging tags, triggers and a dataLayer to surface page events and user interactions for marketing and analytics functions. The implementation focuses on web analytics instrumentation and marketing tag control, with lightweight governance and a small number of administrators managing tag versions and publish workflows appropriate to a 16 person life sciences firm.
|
Aet Biotechnologie IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
IT Decision Makers and Key Stakeholders at Aet Biotechnologie
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Aet Biotechnologie Executives
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||